Invitro Diagnostics, Reagents, Test (FSS-65-VII)

The Veterans Health Administration Veterans Integrated Service Network 12 established this Master GSA Schedule for in vitro diagnostics, reagents, and testing supplies on May 15, 2005, with an ordering deadline of October 31, 2023 — the vehicle is closed to new orders as of nearly two years eight months ago.

The schedule covers 14 subcategories spanning phlebotomy, continuous glucose monitoring units and consumables, blood glucose monitoring units and consumables, hematology, microbiology, coagulation, chemistry, histology/cytology, serology/immunology, blood bank, and miscellaneous diagnostics. Awarded task orders reflect heavy use in reagent procurement, test kits, and consumables across Veterans Affairs medical centers, Indian Health Service facilities, and military medical departments, with recent orders naming BioMérieux BioFire panel reagents, Roche Ventana reagents, Cepheid test kits, Abbott glucose sensors, and point-of-care testing systems as typical buys.

The portfolio shows strong remaining demand despite the closure. Ten thousand task orders have been awarded since first task-order issuance in April 2007, with $879.1 million in combined potential value and $637.5 million obligated (73% of potential). Annual ordering velocity declined from 247 orders in 2022 to 191 in 2025 and 45 in 2026 year-to-date, reflecting the approaching end of a long contract lifecycle rather than loss of customer interest; the most recent task-order award was September 15, 2026. Fifty-one distinct primes share the vehicle; Cepheid leads by potential value ($253.1 million on 2,300 orders), followed by BioFire Diagnostics ($111.5 million), Fisher Scientific ($93.6 million on 5,552 orders), Roche Diagnostics ($70.3 million), and Immucor ($68.3 million). Fisher Scientific owns the order count crown but Cepheid's concentrated value position signals customer preference for high-value test-kit platforms.

One hundred twenty-six customer agencies have ordered; the top five — Indian Health Service, Veterans Integrated Service Network 10, VISN 17, Navy Bureau of Medicine and Surgery, and VISN 8 — account for 36 percent of task-order volume and include significant VA network concentration. Nearly all orders carry no set-aside, with only minimal small-business activity (19 small-business orders of 10,000 total). Task orders are firm fixed price and typically range from roughly $20,000 to $500,000 in individual ceiling values, though outliers including multi-year delivery orders to Cleveland VA Medical Center ($5.4 million ceiling for Roche Ventana reagents) and Medical Center Omaha ($4.3 million for BioFire reagents) demonstrate the scale of sustained laboratory supply agreements.

Blood Bank